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Transferrins comprise a class of monomeric glycoproteins found in all vertebrates, whose function
is iron sequestration and transport. In addition to iron, serum transferrin also binds a variety of
other metals and is believed to provide a route for the in vivo delivery of such metals to cells. In
the present study, ESIMS is used to investigate interactions between human serum transferrin and
two nonferrous metals, indium (a commonly used imaging agent) and bismuth (a component of
many antiulcer drugs). While the UV-Vis absorption spectroscopy measurements clearly indicate
that both metals bind strongly to transferrin in solution, the metal-protein complex can be detected
by ESI MS only for indium, but not for bismuth. Despite the apparently low stability of the
transferrin-bismuth complex in the gas phase, presence of such complex in solution can be
established by ESI MS indirectly. This is done by monitoring the evolution of charge state
distributions of transferrin ions upon acid-induced protein unfolding in the presence and in the
absence of the metal in solution. The anomalous instability of the transferrin-bismuth complex in
the gas phase is rationalized in terms of conformational differences between this form of transferrin
and the holo-forms of this protein produced by binding ofmetals with smaller ionic radii (e.g., Fe3
and In3). The large size of Bi3 ion is likely to prevent formation of a closed conformation
(canonical structure of the holo-protein), resulting in a non-native metal coordination. It is
suggested that transferrin retains the open conformation (characteristic of the apo-form) upon
binding Bi3, with only two ligands in themetal coordination sphere provided by the protein itself.
This suggestion is corroborated by the results of circular dichroism measurements in the near-UV
range. Since the cellular consumption of metals in the transferrin cycle critically depends upon
recognition of the holo-protein complex by the transferrin receptor, the noncanonical conformation
of the transferrin-bismuth complex may explain very inefficient delivery of bismuth to cells even
when a high dosage of bismuth-containing drugs is administered for prolonged periods of
time. (J Am Soc Mass Spectrom 2004, 15, 1658–1664) © 2004 American Society for Mass
SpectrometryTransferrins comprise a class of monomeric bilobalglycoproteins whose function is iron sequestra-tion and transport. The two lobes of the protein
(commonly referred to as N- and C-lobes) have a very
high degree of structural identity and provide two
distinct binding sites for a ferric ion. Binding of Fe3 to
each lobe occurs synergistically with a carboxylic anion
(usually carbonate or oxalate), which provides two
ligands for the hexagonal coordination sphere of the
metal ion. Each lobe undergoes a significant conforma-
tional change upon Fe3 binding by closing the cleft
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doi:10.1016/j.jasms.2004.08.009between two protein domains (Figure 1), which is
usually referred to as a transition from the open (apo-
protein) to the closed (holo-protein) conformation. Hu-
man serum transferrin (hTf) provides a major route for
delivery of otherwise insoluble iron to cells via a
receptor-mediated endocytosis. Only the diferric form
of hTf binds to the receptor (TfR) at the cell surface,
suggesting that the open conformation is not recog-
nized by the receptor. In addition to iron, hTf binds a
variety of other metals, many of them with high effi-
ciency [1]. Since the iron saturation levels of hTf in
circulation is about 30%, it may also serve as a delivery
vehicle for other metals to tissue, provided the protein-
metal complex is recognized by the receptor. There is
strong evidence that the transferrin cycle is a major
cellular uptake route for several metals of great clinical
importance. As such, hTf is often viewed as a promising
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drugs to malignant cells that overexpress TfR [2].
Following a pioneering work by Fenselau and
coworkers[3] and Loo et al. [4], electrospray ioniza-
tion mass spectrometry (ESI MS) has become a potent
tool to study interaction of metal ions with a variety
of biopolymers. Recently, we have shown that ESI MS
can be used to probe interaction between hTf and
Fe3 by monitoring both the composition of the
protein-metal complex and its large-scale conforma-
tional dynamics [5, 6]. The former is done by follow-
ing evolution of the mass of the protein ions, while
the latter is carried out by analyzing their charge state
distribution. We have determined that while the open
and closed conformations of hTf cannot be distin-
guished on the basis of the charge state distributions,
iron binding does delay the onset of the acid-induced
protein unfolding [6]. In the present work we extend
this approach to evaluate interaction of hTf with two
clinically important nonferrous metals, indium, and
bismuth. The former is used as an imaging agent (the
major -emitting isotope currently in clinical use is
111In) [7], while bismuth is often used for treatment of
gastrointestinal disorders, as well as a component of
a variety of antiulcer therapies [8]. There is also a
growing interest in using radioactive isotopes of
bismuth (212Bi and 213Bi) as radiotherapeutic agents
[9]. Both metals bind to hTf with high affinity [10, 11].
Nevertheless, only indium accumulates in tissues
(hence its use as an imaging agent), while systemic
bioavailability of bismuth from its medicinal prepa-
rations is usually very low even at high doses [12],
suggesting very inefficient cellular uptake via trans-
ferrin cycle. Bi3 binds preferentially to hTf (and not
to scavenger proteins, such as albumin [13], or en-
dogenous low molecular weigh organic chelators
[11]) both in aqueous solution and in blood plasma.
Therefore, its inefficient delivery to tissue may be
caused by either (1) altered conformation of the
holo-protein that is not recognized by TfR at the cell
surface or (2) failure of hTf to release Bi3 in the
endosomal compartment at mildly acidic pH. The
Figure 1. Ribbon diagrams of superimposed cr
holo- (1A8E, pink) forms of hTf N-lobe (a). The d
Side chains coordinating iron in the holo-form a
as a gray sphere.results of the present work suggest that the Bi3-bound form of Tf retains the open conformation
(characteristic of the apo-form of the protein), pre-
venting its binding to TfR and internalization.
Experimental
A diferric form of human serum transferrin (Fe2hTf)
was obtained from Sigma Chemical Co. (St. Louis, MO).
The apo-form of the protein was produced by removing
iron using a 1mM EDTA solution containing 3% (by
volume) CH3CO2H. Fe · EDTA complexes were re-
moved from this solution by repetitive ultrafiltration
using 10,000 MWCO microconcentrators (Millipore,
Bedford, MA). In the final step the apo-protein was
buffer-exchanged into 100 mM NH4HCO3. Absence of
iron in the final preparation was verified by ESI MS
measurements. Complexation of hTf with nonferrous
metals (In3 and Bi3) was carried out by incubating the
apo-protein with excess metal · nitrilotriacetate (NTA)
in 100 mM NH4HCO3 (which provided obligatory syn-
ergistic anion) and 50 mM HEPES buffer (pH 7.5) for
1 h. The protein was then buffer-exchanged to 100 mM
NH4HCO3 by ultrafiltration (vide supra) to remove the
excess reagents, followed by a buffer exchange to 10
mMNH4HCO3. In
3 · NTAwas prepared by mixing the
appropriate quantity of the metal (10,000 g/ml In3 in
5% HNO3, plasma standard solution from Alfa Aesar,
Ward Hill, MA) with Na2HNTA (Sigma Chemical Co.).
Bi3 · NTA was prepared from bismuth subcarbonate
(BiO)2CO3 (Sigma Chemical Co.) using a procedure
described elsewhere [14]. Metal binding to hTf in solu-
tion was monitored by measuring difference UV ab-
sorption spectra with a UV-160PC (Shimadzu, Tokyo,
Japan) UV-Vis spectrophotometer. Saturation of hTf
with the metal was inferred from saturation of the
absorption band at 240 nm (Figure 2), which indicates
the extent of de-protonation of tyrosine side chains.
Presence of Bi3 in the final Bix · hTf solution was
additionally verified using electrothermal atomic ab-
sorption spectroscopy (ETAAS) with a 4100ZL (Perkin-
Elmer, Wellesley, MA) graphite furnace atomic absorp-
tion spectrometer.
structures of the apo- (PDB ID 1BP5, blue) and
s of metal coordination are shown on panel (b).
own as stick structures, and ferric ion is shownystal
etail
re shAll mass spectra were acquired on a JMS-700 MSta-
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equipped with a standard ESI source. The pH of protein
solutions (5M in 10 mM CH3CO2NH4) was adjusted
to a desired level using CH3CO2H or NH4OH. All
protein solutions were kept at room temperature (24 °C)
prior to and during ESI MS analysis. The protein
solution was continuously infused into the ESI source at
a flow rate of 3 L/min. The spray needle potential was
kept at below 1.8 kV to avoid in-source oxidation of
protein ions. All mass spectra were acquired by scan-
ning the magnet at a rate of 5 s/decade and the nominal
resolution was set at 1000.
Circular dichroism (CD) measurements were carried
out using a J715 (JASCO, Tokyo, Japan) spectropolarim-
eter (a 1.0 mm cell was for the far-UV measurements
and a 10 mm cell was used for the near-UV
mesuremnts). All CD spectra were normalized based on
the protein concentration.
Results and Discussion
Our previous ESI MS studies of hTf interaction with
Fe3 indicated that both ferric ions remain tightly
Figure 2. Monitoring hTf saturation with Fe3 (top), In3 (mid-
dle), and Bi3 (bottom) using UV absorption spectroscopy. Mul-
tiple traces on the left panels show evolution of the absorption
spectra upon titration of hTf solution with metal·NTA (see Exper-
imental section for detail). Graphs on the left panels show changes
of absorption at 240 nm upon titration.bound to the protein in the gas phase even when veryharsh interface conditions are used to facilitate desol-
vation of protein ions and stripping of synergistic
anions from them [5, 6]. Spectra of the In3-saturated
hTf acquired under the same conditions clearly indicate
presence of two In3 cations in hTf molecule (Figure 3).
Therefore, even though saturation of hTf with In3
occurs at a slightly higher metal-to-protein molar ratio
compared to Fe3 (Figure 2), the (In3)2hTf complex
also displays remarkable stability in the gas phase.
Furthermore, the pattern of the metal ion dissociation
from hTf and conformational stability of the protein
upon mild acidification of the protein solution (Figure
4) are very similar to the behavior displayed by
(Fe3)2hTf under identical solution conditions [6]. Spe-
cifically, no dissociation of In3 from the protein occurs
until the solution pH is lowered to 4.5 (at which point a
protein ion peak corresponding to a mono-metal form
of the protein becomes prominent in the spectrum). Full
dissociation of the metal from hTf occurs only at pH 4.0,
at which point a significant fraction of the protein
undergoes partial unfolding, as evidenced by the ap-
pearance of the high charge density (charge state24 to
32) protein ions in the ESI spectrum. This behavior
contrasts sharply with the conformational stability of
the apo-form of hTf, which is already diminished
greatly at pH 5.5, when hTf shows clear signs of partial
unfolding as evidenced by the appearance of high
charge density protein ion peaks in the ESI mass spectra
(Figure 4).
Bi3 is another metal ion that binds to hTf very
strongly in aqueous solution, second only to ferric ion
[15]. The difference absorption spectroscopy measure-
ments indicate that hTf becomes fully saturated with
Bi3 at ca. 3.5 metal-to-protein molar ratio. However, no
(Bi3)xhTf (x 1, 2) complexes have been detected with
ESI MS after bismuth-saturated hTf solution was buffer-
Figure 3. Peak shapes of molecular ions of hTf (charge state20)
in ESI mass spectra of apo protein solid line, as well as metal-
saturated protein (Fe3 dash dot line, In3 dash line, and Bi3 dot
line).exchanged to ammonium acetate (Figure 3). No metal-
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desolvation conditions (data not shown). To eliminate
the possibility of bismuth dissociation from the protein
during the buffer exchange step followed by its removal
from the solution during ultrafiltration, presence of this
metal in the final protein solution was independently
verified by atomic absorption spectroscopy (ETAAS).
Despite the failure to detect the putative (Bi3)xhTf
complexes directly using ESI MS, binding of Bi3 to hTf
in solution can be inferred from the changes of the
protein conformational flexibility in the presence of this
metal. ESI MS measurements carried out under mildly
acidic conditions clearly indicate that hTf remains
tightly folded (compact conformation) in the presence
of bismuth until the solution pH is lowered below 4.5
(Figure 4). This behavior is similar to that displayed by
both (Fe3)2hTf and (In
3)2hTf complexes and differs
significantly from that of the metal-free form of hTf
(vide supra). The fact that presence of Bi3 in solution
(which was verified by ETAAS measurements) has a
significant stabilizing effect on the protein (the unfold-
ing onset is “delayed” by more than one pH unit)
suggests that the protein-metal binding does occur in
solution, although the complex becomes unstable in the
Figure 4. Evolution of charge state distribution
panel), Bi3-saturated hTf (middle panel), and I
unfolding.
Table 1. Binding of various metals to hTf in solution
Metal cation
Ionic radius, Å
(as reported in [29]) logK1
Fe3 0.65 20.7
In3 0.80 18.5
Bi3 1.03 19.4gas phase and dissociates, thus preventing the direct
detection of the protein-metal binding.
One of the likely causes of the extreme instability of
the (Bi3)xhTf complex ions in the gas phase may be a
different coordination of bismuth by hTf, compared to
other metals. Bi3 is significantly larger than Fe3 and
In3 (see Table 1), and insertion of this ion into the
metal-binding cleft of hTf may prevent closure of the
cleft, leaving the protein in the open conformation
(characteristic of its apo-form). Furthermore, coordina-
tion preferences of Bi(III) (which exhibits a variable
coordination number, ranging from 3 to 10, and often
has an irregular coordination geometry [16]) may be
sufficiently different from those of Fe3 and In3, thus
making alternative (non-native) metal ion coordination
geometry of hTf more energetically favorable. Previous
studies (reviewed by Harris et al. in [17]) suggest that
neither N- nor C-lobe of transferrin has a significant size
restriction for metals with radii up to 0.95 Å, although
there may be exceptions from this empirical rule. A few
metal ions whose ionic radii fall below the 0.95 Å limit
bind to hTf without inducing closure of the metal-
binding cleft (e.g., 0.83 Å Hf4 [18] and 0.84 Å Zr4
[19]), most likely due to their strong preference to the
protein ions in ESI mass spectra of apo-hTf (left
aturated hTf (right panel) in the course of acid
logK2 Comments Reference
19.4 pH 7.4 [30]
16.4 pH 7.4 (5 mM
sodium bicarbonate)
[31]
18.6 pH 7.4 (5 mM [16]s of
n3-sbicarbonate, 310 K)
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in the closed conformation of hTf.
The ionic radius of In3 falls within the “allowed”
range, thus explaining the ability of this metal to induce
a conformational transition from the open to the closed
form of both lobes of hTf upon binding to this protein.
On the other hand, the ionic radius of Bi3 exceeds the
0.95 Å limit (Table 1), which suggests that geometric
restrictions may play a role in determining the confor-
mation of the metal-bound protein. However, the re-
sults of the earlier NMR measurements of bismuth-
bound hTf carried out by Sadler and co-workers have
been interpreted in terms of the closed structure as-
sumed by the protein as a result of metal binding. These
conclusions were based on the similarity of 1H reso-
nance shifts induced by Bi3 and Fe3 binding to hTf
[20, 21]. The following studies of bismuth-hTf complex
using two-dimensional 1H, 13C hetero-nuclear single-
quantum coherence (HSQC) NMR spectroscopy did
reveal some differences in evolution of the resonance
peaks for methionine residues (used as reporters of
tertiary structural changes) upon titration of the N-lobe
of hTf with Fe3 and Bi3 [13].
To evaluate the putative structural changes within
hTf upon bismuth binding, circular dichroism (CD)
spectra of both apo- and metal-saturated forms of the
protein have been recorded in the far- and near-UV
regions (Figure 5). Near-UV CD spectroscopy is often
used to probe tertiary structure of proteins and their
complexes, as the intensities of the aromatic residue
bands (phenylalanine at 255–270 nm, tyrosine at 280 nm
and tryptophan at 290 nm, as labeled on Figure 5)
depend on a unique orientation of these chromophores,
as determined by the higher order structure of the
protein [22]. Near-UV CD spectroscopy had been used
in the past as a probe of structural changes induced by
Figure 5. Near-UV CD spectra of Fe3-saturated hTf, In3-
saturated hTf, Bi3-saturated hTf and apo-hTf. The far-UV CD
spectra are shown on the inset.metal binding to various proteins from the transferrinfamily [23, 24]. Presence of certain extrinsic factors
(such as a prosthetic heme group) may complicate the
analysis of near-UV CD data, as coupling of the elec-
tronic transitions may lead to the appearance of bands
not initially present in the apo-protein spectrum (an
example of that is a Soret band in CD spectra of
heme-bound proteins). Fortunately, no strong coupling
occurs in the 250–400 nm range between the electronic
transitions of Bi3 and those of the protein, as suggested
by the absence of the new bands in the CD spectrum of
Bi3-saturated hTf as compared to the apo-form of this
protein (Figure 5). Most importantly, presence of Bi3
does not alter the shapes and intensities of the aromatic
bands, indicating very little (if any) changes in the
tertiary structure of hTf upon Bi3 binding. At the same
time, the CD spectra of In3- and Fe3-saturated hTf
exhibit very significant deviations from the spectrum of
the apo-protein. Although some of these differences are
clearly related to strong coupling of the electronic
transitions (e.g., a strong positive band above 300 nm in
the (Fe3)2hTf spectrum and a negative band below 270
nm in the (In3)2hTf spectrum), the intensity changes in
the intrinsic aromatic bands are also apparent (Figure 5)
and are likely to reflect a change in the protein tertiary
structure induced by metal binding. At the same time,
neither Bi3 nor the other two metals induce any
noticeable changes in the far-UV CD spectra of hTf
(inset in Figure 5), consistent with the notion that the
protein secondary structure is not altered upon metal
binding.
In order to rationalize Bi3 binding to the open
conformation of hTf, it is instructive to consider the
available crystal structures of iron-loaded forms of hen
ovotransferrin N-lobe [25] and camel lactoferrin [26],
which had been forced to stay in the open conformation
characteristic of the apo-form (by soaking the apo-
protein crystals in concentrated Fe3 solution followed
by crystal drying). Coordination of Fe3 ion in each case
is provided by two Tyr residues that participate in
metal coordination in the native (closed) conformation
of the holo-protein. The rest of the coordination sphere
is completed in each case by small organic ligands (a
multidentate nitrilotriacetate anion completing a six-
coordinate sphere in the case of hen ovotransferrin
N-lobe and a bidentate carbonate completing a four-
coordinate sphere in the case of camel lactoferrin).
These alternative structural states of iron-bound pro-
teins from the transferrin family are suggested to rep-
resent transient intermediate states on the Fe3-binding
pathway. This view is consistent with a hypothesis
articulated recently by Baker et al. [27], who suggested
that apo-transferrins actually sample both conforma-
tions (open and closed), however the open state is
energetically favorable. The two tyrosines are suggested
to be the initial metal binding site. Once the metal
associates to this site, the conformational equilibrium
(open _ closed) will shift towards the closed state (in
mechanistic terms, the other domain will lock on as the
protein samples the closed conformation).
1663J Am Soc Mass Spectrom 2004, 15, 1658–1664 INTERACTION OF TRANSFERRIN WITH NONFERROUS METALSAlthough Bi3 is a borderline Lewis acid (unlike
Fe3, which is a hard acid), it has a high affinity for
oxygen ligands in aqueous solution [16]. Therefore, it is
very likely that the initial binding of both Bi3 and Fe3
to hTf proceeds in a similar fashion (i.e., binding to the
phenolate groups of the two Tyr residues). However,
the large ionic radius of Bi3 makes it impossible to
proceed to the next step, in which the closed conforma-
tion is sampled, and the closure of the binding cleft
brings the requisite metal-coordinating residues (Asp63
and His249) into proximity with the metal ion, thus
completing the coordination sphere (Figure 6). The
minimum coordination number for Bi3 is three and the
maximum is ten [16]. Earlier 13C NMR measurement
indicate that carbonate binds to the N-lobe of hTf
concomitantly with Bi3 [21] and, therefore, is likely to
provide two more ligands to the metal coordination
sphere (additional ligands can be provided by water
molecules filling the open cleft). An easy removal of
such ligands from the metal coordination sphere in the
gas phase is likely to weaken the protein-metal ion
interaction energy very significantly, leading to facile
dissociation of the complex.
The intriguing ability of Bi3 to stabilize the open
conformation of hTf (characteristic of the apo-form)
provides unique opportunities to study dynamics of
this protein. Our current studies of hTf dynamics using
hydrogen/deuterium exchange (HDX) clearly indicate
that the protein backbone amide hydrogen atoms are
significantly less protected in the apo-form of the pro-
tein (Zhang, et al., unpublished). However, the results
of such measurements cannot be interpreted unequiv-
ocally, as the difference in HDX kinetics can be attrib-
uted to both lower solvent exposure of the closed form
of the protein (structural aspect) and decreased flexibil-
ity of the backbone due to the stabilizing effect of the
metal (dynamic aspect) [28]. Stabilization of the open
conformation of hTf with Bi3 ions eliminates such
ambiguity, thus allowing direct and independent anal-
ysis of the two aspects of the protein behavior.
Conclusions
Despite very high binding affinity in solution, a
Figure 6. A diagram of metal binding by a sin
closing of the metal-binding cleft (a), while a l
protein to remain in the open conformation (b).straightforward use of ESI MS to detect the Bi3-hTffails due to the instability of the metal-protein complex
ion in the gas phase. Since other metals having similar
binding affinities form complexes that are very stable in
the gas phase, the anomalous behavior of Bi3is inter-
preted in terms of non-native coordination geometry of
this metal in the metal-binding cleft of transferrin. The
unusual coordination of this metal is caused by its large
ionic radius, which prevents formation of the closed
conformation of transferrin (characteristic of its holo-
form). The assumption of the closed conformation by
hTf is critical for its recognition by the receptor at the
cell surface and, therefore, metal delivery to the cell.
The failure of the Bi3-loaded hTf to adopt a “proper”
conformation may explain low levels of bismuth accu-
mulation in tissues even when a high dosage of bismuth
containing drugs is administered for prolonged periods
of time.
Despite the facile dissociation of the Bi3-hTf com-
plex in the gas phase, the protein-metal ion binding in
solution can be confidently detected with ESI MS using
an indirect approach. The latter relies on monitoring
charge state distribution of the protein ions to detect
changes in the conformational stability of the protein in
solution caused by the metal binding. This experimental
approach can find general use for indirect detection of
protein-ligand interactions in solution when the com-
plex is unstable in the gas phase and, therefore, eludes
direct detection with ESI MS (e.g., when the hydropho-
bic interactions play a major role in complex formation).
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